MedTrace Logo

Sperm, Exposure and Endocrine Disruptors

NCT07703046 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-07-14

No results posted yet for this study

Summary

The proposed research aims to 1) measure male participants' urinary levels of EDCs and sperm quality before and after report-back and EDC reduction intervention and assess changes, 2) assess the extent to which MM's program (testing, curriculum, and report-back) alters participant environmental health literacy (EHL), readiness to change (RtC), and product/lifestyle choices, and 3) test the feasibility and acceptability of MM's program to male participants. The primary study subjects are adult men of reproductive age. The study aims to have 60 participants complete the study.

Conditions

  • Fertility
  • Male Fertility
  • Sperm Count, Low
  • Sperm Quality

Interventions

BEHAVIORAL

EDC Education Intervention

Participants receive a 14 module intervention program about endocrine disrupting chemicals and reducing exposures. Participants must complete at least 8 modules over the course of 8 weeks.

Sponsors & Collaborators

  • Fellow Health, Inc.

    collaborator INDUSTRY

  • National Institute of Environmental Health Sciences (NIEHS)

    collaborator NIH

  • Million Marker Wellness, Inc.

    lead INDUSTRY

Principal Investigators

  • Johanna Rochester, PhD · Million Marker Wellness

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07703046 on ClinicalTrials.gov